Neumora Therapeutics (NMRA)
Neumora Therapeutics on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances).
6.7M
Short interest
settlement 2026-09-30
2.7
Days to cover
-6.3 days vs prior
71.3%
Short share of volume
2026-10-23
2,250
Fails to deliver
settlement 2026-09-21
Thu 5 Nov
Next earnings
estimated date
-$702K
Insider flow, 90 days
0 buys, 11 sells
As of 2026-10-23.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in NMRA is 6,692,034 shares, down 1,335,626 shares over the last month. Over the last 48 readings it ranged from 4,326,409 shares (31 March 2026) to 15,021,286 shares (30 May 2025). At the reported average volume of 2.5M shares a day that is 2.7 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/nmra" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 6,692,034 | -4.1% | 2,491,344 | 2.69 |
| 2026-09-15 | 6,979,674 | -13.1% | 773,503 | 9.02 |
| 2026-08-31 | 8,027,660 | +0.5% | 788,846 | 10.18 |
| 2026-08-14 | 7,991,116 | +4.8% | 596,204 | 13.40 |
| 2026-07-31 | 7,622,548 | -2.1% | 692,473 | 11.01 |
| 2026-07-15 | 7,786,397 | +16.5% | 1,029,524 | 7.56 |
| 2026-06-30 | 6,682,749 | +35.9% | 6,013,588 | 1.11 |
| 2026-06-15 | 4,917,298 | -11.9% | 2,262,846 | 2.17 |
| 2026-05-29 | 5,581,263 | +14.0% | 1,109,768 | 5.03 |
| 2026-05-15 | 4,897,401 | +6.4% | 1,648,146 | 2.97 |
| 2026-04-30 | 4,601,847 | +3.0% | 1,343,158 | 3.43 |
| 2026-04-15 | 4,469,003 | +3.3% | 1,276,794 | 3.50 |
| 2026-03-31 | 4,326,409 | -12.8% | 1,073,677 | 4.03 |
| 2026-03-13 | 4,958,521 | -5.0% | 1,009,316 | 4.91 |
| 2026-02-27 | 5,216,610 | -13.7% | 870,409 | 5.99 |
| 2026-02-13 | 6,045,735 | +7.3% | 2,352,055 | 2.57 |
| 2026-01-30 | 5,634,962 | -5.9% | 886,052 | 6.36 |
| 2026-01-15 | 5,986,621 | -20.2% | 3,853,615 | 1.55 |
| 2025-12-31 | 7,502,647 | +7.5% | 898,985 | 8.35 |
| 2025-12-15 | 6,982,708 | +7.9% | 975,533 | 7.16 |
| 2025-11-28 | 6,468,823 | +6.1% | 970,047 | 6.67 |
| 2025-11-14 | 6,095,137 | -6.8% | 1,503,981 | 4.05 |
| 2025-10-31 | 6,542,312 | -3.6% | 4,593,092 | 1.42 |
| 2025-10-15 | 6,788,203 | +0.2% | 570,462 | 11.90 |
| 2025-09-30 | 6,775,172 | +5.6% | 496,148 | 13.66 |
| 2025-09-15 | 6,417,308 | +22.6% | 378,111 | 16.97 |
| 2025-08-29 | 5,233,308 | -0.8% | 364,017 | 14.38 |
| 2025-08-15 | 5,276,271 | -26.4% | 948,129 | 5.56 |
| 2025-07-31 | 7,164,533 | -20.7% | 2,295,320 | 3.12 |
| 2025-07-15 | 9,032,623 | -14.1% | 1,853,209 | 4.87 |
| 2025-06-30 | 10,516,854 | -27.7% | 1,687,479 | 6.23 |
| 2025-06-13 | 14,543,296 | -3.2% | 1,064,758 | 13.66 |
| 2025-05-30 | 15,021,286 | +9.9% | 793,222 | 18.94 |
| 2025-05-15 | 13,664,444 | +6.9% | 869,565 | 15.71 |
| 2025-04-30 | 12,784,957 | -3.8% | 905,098 | 14.13 |
| 2025-04-15 | 13,295,536 | +3.6% | 1,171,212 | 11.35 |
| 2025-03-31 | 12,828,172 | -0.5% | 1,284,058 | 9.99 |
| 2025-03-14 | 12,894,062 | +5.0% | 1,243,835 | 10.37 |
| 2025-02-28 | 12,279,064 | +9.6% | 1,447,531 | 8.48 |
| 2025-02-14 | 11,199,944 | +9.2% | 1,665,782 | 6.72 |
| 2025-01-31 | 10,256,517 | -7.0% | 2,945,015 | 3.48 |
| 2025-01-15 | 11,030,285 | -15.1% | 12,006,978 | 1.00 |
| 2024-12-31 | 12,989,499 | +19.9% | 894,644 | 14.52 |
| 2024-12-13 | 10,833,211 | +3.6% | 931,566 | 11.63 |
| 2024-11-29 | 10,457,148 | +6.5% | 860,653 | 12.15 |
| 2024-11-15 | 9,813,966 | +4.8% | 1,202,864 | 8.16 |
| 2024-10-31 | 9,367,098 | +4.0% | 1,386,574 | 6.76 |
| 2024-10-15 | 9,008,776 | -7.0% | 1,083,506 | 8.31 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 October 2026, the short share of NMRA volume is 71.3%, up 13.8 points over the last five sessions. Over the last 30 readings it ranged from 33.0% (28 September 2026) to 79.8% (5 October 2026). The latest reading is 13.2 points above the 30-session average of 58.1%, on 426K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-23 | 304K | 426K | 71.3% | 160 |
| 2026-10-22 | 292K | 424K | 68.9% | 40,823 |
| 2026-10-21 | 353K | 867K | 40.7% | 15,808 |
| 2026-10-20 | 268K | 427K | 62.9% | 0 |
| 2026-10-19 | 477K | 798K | 59.7% | 56 |
| 2026-10-16 | 1.1M | 2.0M | 57.5% | 4,200 |
| 2026-10-15 | 2.9M | 4.4M | 66.9% | 384,418 |
| 2026-10-14 | 1.1M | 1.4M | 76.7% | 215,152 |
| 2026-10-13 | 379K | 741K | 51.2% | 17,662 |
| 2026-10-12 | 429K | 781K | 54.9% | 2,471 |
| 2026-10-09 | 235K | 435K | 54.1% | 0 |
| 2026-10-08 | 519K | 654K | 79.3% | 1,963 |
| 2026-10-07 | 1.1M | 1.8M | 61.7% | 135,499 |
| 2026-10-06 | 438K | 720K | 60.9% | 28,717 |
| 2026-10-05 | 1.4M | 1.7M | 79.8% | 172,505 |
| 2026-10-02 | 805K | 1.7M | 48.2% | 15,504 |
| 2026-10-01 | 717K | 1.7M | 42.7% | 55,576 |
| 2026-09-30 | 943K | 1.4M | 69.8% | 34,792 |
| 2026-09-29 | 323K | 704K | 45.9% | 1,636 |
| 2026-09-28 | 834K | 2.5M | 33.0% | 33,817 |
| 2026-09-25 | 640K | 1.3M | 49.3% | 26,997 |
| 2026-09-24 | 360K | 756K | 47.6% | 33,384 |
| 2026-09-23 | 487K | 803K | 60.6% | 31,316 |
| 2026-09-22 | 1.1M | 1.8M | 61.6% | 0 |
| 2026-09-21 | 647K | 918K | 70.5% | 0 |
| 2026-09-18 | 728K | 1.7M | 42.9% | 0 |
| 2026-09-17 | 905K | 2.0M | 44.2% | 0 |
| 2026-09-16 | 1.5M | 2.0M | 74.8% | 158,917 |
| 2026-09-15 | 521K | 755K | 68.9% | 43,504 |
| 2026-09-14 | 91K | 254K | 35.9% | 2,625 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 21 September 2026, the fails-to-deliver balance in NMRA is 2,250 shares, down 89,670 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (27 January 2026) to 305,905 shares (29 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-21 | 2,250 | $0.73 | $2K |
| 2026-08-27 | 91,920 | $1.56 | $143K |
| 2026-08-13 | 1,273 | $1.71 | $2K |
| 2026-08-11 | 20,936 | $1.62 | $34K |
| 2026-07-16 | 6,539 | $1.63 | $11K |
| 2026-06-30 | 6,255 | $1.72 | $11K |
| 2026-06-29 | 305,905 | $1.64 | $502K |
| 2026-06-26 | 183 | $1.51 | $276 |
| 2026-06-25 | 183 | $1.46 | $267 |
| 2026-06-22 | 3,161 | $1.51 | $5K |
| 2026-06-18 | 3,161 | $1.53 | $5K |
| 2026-06-17 | 17,998 | $1.56 | $28K |
| 2026-01-27 | 1 | $2.04 | $2 |
| 2026-01-20 | 714 | $2.02 | $1K |
| 2026-01-16 | 1,880 | $2.13 | $4K |
| 2026-01-14 | 474 | $2.14 | $1K |
| 2026-01-12 | 3,234 | $2.22 | $7K |
| 2026-01-09 | 3 | $2.33 | $7 |
| 2025-12-30 | 7,400 | $1.78 | $13K |
| 2025-12-16 | 5,510 | $1.96 | $11K |
| 2025-12-02 | 1,989 | $2.42 | $5K |
| 2025-11-24 | 34,100 | $2.33 | $79K |
| 2025-11-19 | 37 | $2.66 | $98 |
| 2025-11-18 | 88 | $2.59 | $228 |
| 2025-11-17 | 71 | $2.65 | $188 |
| 2025-11-14 | 119 | $2.69 | $320 |
| 2025-11-12 | 120,575 | $2.75 | $332K |
| 2025-11-07 | 131 | $2.58 | $338 |
| 2025-10-31 | 3,336 | $2.93 | $10K |
| 2025-10-29 | 2,584 | $2.59 | $7K |
Insider trades
SEC Form 4, newest first. JSONInsiders at NMRA reported 11 open-market sells worth $702K in the last 90 days and no open-market buys. Latest filing: Aurora Daljit Singh (See Remarks) on 2026-08-21.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-21 | Aurora Daljit Singh | See Remarks | Sell | 21K | $1.60 | $34K | 0 |
| 2026-08-21 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 21K | $0.72 | $15K | 21K |
| 2026-08-21 | Aurora Daljit Singh | See Remarks | Sell | 21K | $1.59 | $33K | 49K |
| 2026-08-21 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 21K | $0.72 | $15K | 69K |
| 2026-08-20 | Aurora Daljit Singh | See Remarks | Sell | 67K | $1.51 | $101K | 0 |
| 2026-08-20 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 45K | $0.72 | $32K | 67K |
| 2026-08-20 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 22K | $0.72 | $16K | 22K |
| 2026-08-20 | Aurora Daljit Singh | See Remarks | Sell | 68K | $1.51 | $103K | 49K |
| 2026-08-20 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 68K | $0.72 | $49K | 116K |
| 2026-08-19 | Aurora Daljit Singh | See Remarks | Sell | 31K | $1.65 | $51K | 0 |
| 2026-08-19 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 31K | $0.72 | $22K | 31K |
| 2026-08-19 | Aurora Daljit Singh | See Remarks | Sell | 31K | $1.65 | $51K | 49K |
| 2026-08-19 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 18K | $0.72 | $13K | 80K |
| 2026-08-19 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 13K | $0.72 | $10K | 62K |
| 2026-08-18 | Aurora Daljit Singh | See Remarks | Sell | 35K | $1.59 | $55K | 0 |
| 2026-08-18 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 35K | $0.72 | $25K | 35K |
| 2026-08-18 | Aurora Daljit Singh | See Remarks | Sell | 34K | $1.58 | $54K | 49K |
| 2026-08-18 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 34K | $0.72 | $25K | 83K |
| 2026-08-17 | Aurora Daljit Singh | See Remarks | Sell | 55K | $1.50 | $83K | 0 |
| 2026-08-17 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 30K | $0.72 | $21K | 55K |
| 2026-08-17 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 25K | $0.72 | $18K | 25K |
| 2026-08-17 | Aurora Daljit Singh | See Remarks | Sell | 34K | $1.49 | $51K | 49K |
| 2026-08-17 | Aurora Daljit Singh | See Remarks | Sell | 58K | $1.51 | $87K | 83K |
| 2026-08-17 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 1 | $0.72 | $1 | 140K |
| 2026-08-17 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 1K | $0.72 | $1K | 140K |
| 2026-08-17 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 15K | $0.72 | $11K | 139K |
| 2026-08-17 | Aurora Daljit Singh | See Remarks | Exercise or conversion | 41K | $0.72 | $29K | 124K |
| 2026-02-17 | Pinto Joshua | President | Sell | 6K | $3.54 | $21K | 58K |
| 2026-02-17 | Milligan Michael Lee | See Remarks | Sell | 1K | $3.56 | $5K | 21K |
| 2026-02-17 | BERNS PAUL L | See Remarks | Sell | 10K | $3.51 | $34K | 7.4M |
| 2026-02-17 | Aurora Daljit Singh | See Remarks | Sell | 6K | $3.56 | $22K | 83K |
| 2025-11-11 | Aurora Daljit Singh | See Remarks | Sell | 115K | $2.68 | $307K | 0 |
| 2025-10-27 | ARCH Venture Partners VIII, LLC | TenPercentOwner | Buy | 1.9M | $2.61 | $5.0M | 6.0M |
| 2025-10-27 | Burow Kristina | Director, 10% owner | Buy | 1.9M | $2.61 | $5.0M | 6.0M |
| 2025-10-27 | ARCH Venture Partners XII, LLC | 10% owner | Buy | 1.9M | $2.61 | $5.0M | 6.0M |
| 2025-10-27 | ARCH Venture Partners X, LLC | 10% owner | Buy | 1.9M | $2.61 | $5.0M | 6.0M |
| 2025-05-21 | Pinto Joshua | President | Gift | 13K | $0.00 | $0 | 152K |
| 2025-05-21 | Pinto Joshua | President | Gift | 13K | $0.00 | $0 | 64K |
| 2025-02-18 | Pinto Joshua | President | Sell | 8K | $1.67 | $13K | 77K |
| 2025-02-18 | Lenz Robert A. | Head of R&D | Sell | 6K | $1.67 | $9K | 309K |
| 2025-02-18 | Aurora Daljit Singh | Chief Strategy Officer | Sell | 9K | $1.68 | $14K | 89K |
| 2025-02-18 | Milligan Michael Lee | See Remarks | Sell | 2K | $1.69 | $3K | 22K |
| 2025-02-18 | BERNS PAUL L | See Remarks | Sell | 14K | $1.69 | $23K | 7.4M |
| 2024-12-27 | BERNS PAUL L | Director | Gift | 133K | $0.00 | $0 | 7.4M |
| 2024-12-27 | BERNS PAUL L | Director | Gift | 133K | $0.00 | $0 | 7.6M |
| 2024-12-27 | BERNS PAUL L | Director | Gift | 133K | $0.00 | $0 | 7.7M |
| 2024-10-18 | Fust Matthew K | Director | Sell | 14K | $17.03 | $239K | 20K |
| 2024-10-18 | Fust Matthew K | Director | Exercise or conversion | 8K | $2.52 | $20K | 34K |
| 2024-10-18 | Fust Matthew K | Director | Exercise or conversion | 6K | $8.79 | $55K | 26K |
| 2024-10-17 | Fust Matthew K | Director | Sell | 8K | $17.01 | $132K | 20K |
| 2024-10-17 | Fust Matthew K | Director | Exercise or conversion | 2K | $2.52 | $5K | 28K |
| 2024-10-17 | Fust Matthew K | Director | Exercise or conversion | 2K | $8.79 | $16K | 26K |
| 2024-10-17 | Fust Matthew K | Director | Exercise or conversion | 4K | $8.32 | $31K | 24K |
| 2024-10-10 | Lenz Robert A. | Head of R&D | Sell | 8K | $15.09 | $125K | 315K |
| 2024-10-09 | Lenz Robert A. | Head of R&D | Sell | 6K | $15.01 | $84K | 323K |
| 2024-09-18 | Lenz Robert A. | Head of R&D | Sell | 11K | $12.09 | $129K | 329K |
| 2024-09-17 | Lenz Robert A. | Head of R&D | Sell | 31K | $11.81 | $364K | 339K |
| 2024-09-12 | Lenz Robert A. | Head of R&D | Sell | 33K | $11.43 | $377K | 370K |
| 2024-08-27 | Pinto Joshua | Chief Financial Officer | Sell | 16K | $11.39 | $179K | 139K |
| 2024-08-26 | Pinto Joshua | Chief Financial Officer | Sell | 32K | $11.78 | $373K | 155K |
| 2024-08-23 | Pinto Joshua | Chief Financial Officer | Sell | 24K | $11.59 | $280K | 186K |
| 2024-08-22 | Pinto Joshua | Chief Financial Officer | Sell | 28K | $11.63 | $331K | 210K |
| 2024-06-13 | Burow Kristina | Director,TenPercentOwner | Grant | 20K | $0.00 | $0 | 48K |
| 2024-06-13 | Fust Matthew K | Director | Grant | 20K | $0.00 | $0 | 20K |
| 2024-06-13 | Halawa Alaa | Director | Grant | 20K | $0.00 | $0 | 20K |
| 2024-06-13 | Piacquad David | Director | Grant | 20K | $0.00 | $0 | 20K |
| 2024-06-13 | Ho Maykin | Director | Grant | 20K | $0.00 | $0 | 20K |
| 2024-04-22 | Aurora Daljit Singh | Chief Strategy Officer | Gift | 115K | $0.00 | $0 | 98K |
| 2024-04-17 | Pinto Joshua | Chief Financial Officer | Gift | 239K | $0.00 | $0 | 239K |
| 2024-02-14 | Lenz Robert A. | Head of R&D | Grant | 50K | $0.00 | $0 | 403K |
| 2024-02-14 | Milligan Michael Lee | See Remarks | Grant | 21K | $0.00 | $0 | 24K |
| 2024-02-14 | Gosebruch Henry O | President & CEO | Grant | 80K | $0.00 | $0 | 462K |
| 2024-02-14 | BERNS PAUL L | Director | Grant | 171K | $0.00 | $0 | 7.8M |
| 2024-02-14 | Suh Carol Y. | Chief Operating Officer | Grant | 85K | $0.00 | $0 | 375K |
| 2024-02-14 | Aurora Daljit Singh | Chief Strategy Officer | Grant | 98K | $0.00 | $0 | 212K |
| 2024-02-14 | Pinto Joshua | Chief Financial Officer | Grant | 85K | $0.00 | $0 | 324K |
| 2023-12-08 | Burow Kristina | Director,TenPercentOwner | Other transaction | 1.2M | price not stated in the filing | not stated | 4.1M |
| 2023-12-08 | Burow Kristina | Director,TenPercentOwner | Other transaction | 14K | price not stated in the filing | not stated | 28K |
| 2023-12-08 | Burow Kristina | Director,TenPercentOwner | Other transaction | 703K | price not stated in the filing | not stated | 1.4M |
| 2023-12-08 | ARCH Venture Partners X, L.P. | TenPercentOwner | Other transaction | 1.2M | price not stated in the filing | not stated | 2.3M |
| 2023-12-08 | ARCH Venture Partners X, L.P. | TenPercentOwner | Other transaction | 703K | price not stated in the filing | not stated | 1.4M |
| 2023-12-08 | ARCH Venture Partners XII, LLC | TenPercentOwner | Other transaction | 1.2M | price not stated in the filing | not stated | 2.3M |
| 2023-12-08 | ARCH Venture Partners XII, LLC | TenPercentOwner | Other transaction | 703K | price not stated in the filing | not stated | 1.4M |
| 2023-11-14 | ARCH Venture Fund XII, L.P. | TenPercentOwner | Buy | 3K | $11.98 | $40K | 4.1M |
| 2023-11-14 | Burow Kristina | Director,TenPercentOwner | Buy | 3K | $11.98 | $40K | 4.1M |
| 2023-11-13 | ARCH Venture Fund XII, L.P. | TenPercentOwner | Buy | 32K | $11.75 | $372K | 4.1M |
| 2023-11-13 | Burow Kristina | Director,TenPercentOwner | Buy | 32K | $11.75 | $372K | 4.1M |
| 2023-11-10 | ARCH Venture Fund XII, L.P. | TenPercentOwner | Buy | 5K | $11.75 | $64K | 4.1M |
| 2023-11-10 | ARCH Venture Fund XII, L.P. | TenPercentOwner | Buy | 12K | $11.37 | $135K | 4.1M |
| 2023-11-10 | Burow Kristina | Director,TenPercentOwner | Buy | 12K | $11.37 | $135K | 4.1M |
| 2023-11-10 | Burow Kristina | Director,TenPercentOwner | Buy | 5K | $11.75 | $64K | 4.1M |
| 2023-11-09 | ARCH Venture Fund XII, L.P. | TenPercentOwner | Buy | 31K | $10.53 | $327K | 4.1M |
| 2023-11-09 | Burow Kristina | Director,TenPercentOwner | Buy | 31K | $10.53 | $327K | 4.1M |
| 2023-11-08 | ARCH Venture Fund XII, L.P. | TenPercentOwner | Buy | 69K | $10.78 | $745K | 4.0M |
| 2023-11-08 | ARCH Venture Fund XII, L.P. | TenPercentOwner | Buy | 23K | $11.79 | $273K | 4.0M |
| 2023-11-08 | Burow Kristina | Director,TenPercentOwner | Buy | 69K | $10.78 | $745K | 4.0M |
| 2023-11-08 | Burow Kristina | Director,TenPercentOwner | Buy | 23K | $11.79 | $273K | 4.0M |
| 2023-11-07 | ARCH Venture Partners XII, LLC | TenPercentOwner | Buy | 30K | $11.50 | $347K | 4.0M |
| 2023-11-07 | Burow Kristina | Director,TenPercentOwner | Buy | 30K | $11.50 | $347K | 4.0M |
| 2023-11-06 | ARCH Venture Partners XII, LLC | TenPercentOwner | Buy | 43K | $11.55 | $498K | 3.9M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON10 Form 144 notices on file for NMRA worth $1.1M at the prices reported; 5 in the last 90 days worth $702K. Latest: Aurora Daljit Singh filed on 2026-08-21 to sell 41,608 shares ($66K) from 2026-08-21.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-21 | Aurora Daljit SinghOfficer | 42K | $66K | 0.022% | 2026-08-21 | Merrill Lynch |
| 2026-08-20 | Aurora Daljit SinghOfficer | 134K | $204K | 0.072% | 2026-08-20 | Merrill Lynch |
| 2026-08-19 | Aurora Daljit SinghOfficer | 62K | $102K | 0.033% | 2026-08-19 | Merrill Lynch |
| 2026-08-18 | Aurora Daljit SinghOfficer | 69K | $110K | 0.037% | 2026-08-18 | Merrill Lynch |
| 2026-08-17 | Aurora Daljit SinghOfficer | 147K | $220K | 0.078% | 2026-08-17 | Merrill Lynch |
| 2026-02-17 | Pinto JoshuaOfficer | 6K | $21K | 0.004% | 2026-02-17 | Merrill Lynch |
| 2026-02-17 | Milligan Michael LeeOfficer | 1K | $5K | 0.001% | 2026-02-17 | Merrill Lynch |
| 2026-02-17 | BERNS PAUL LOfficer | 10K | $34K | 0.006% | 2026-02-17 | Merrill Lynch |
| 2026-02-17 | Aurora Daljit SinghOfficer | 6K | $22K | 0.004% | 2026-02-17 | Merrill Lynch |
| 2025-11-12 | Aurora Family TrustDirector, Officer | 115K | $307K | 0.069% | 2025-11-11 | Merrill Lynch |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON17 holders report 5% or more of NMRA in their latest filing, all on Schedule 13D (active intent). The largest reported stake is Kristina Burow at 18.7% of the class (33,965,419 shares), filed 2026-04-01 for an event on 2026-03-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-05-15 | 13G/Ano. 2 | Parag Shahindividual, parent holding company | 5.8M | 3.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | K2 HealthVentures Equity Trust LLCother entity | 5.8M | 3.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Anup Aroraindividual, parent holding company | 5.8M | 3.1% | 2026-03-31 |
| 2026-05-04 | 13G/Ano. 1 | Raymond Debbaneindividual | 8.5M | 4.7% | 2026-03-31 |
| 2026-05-04 | 13G/Ano. 1 | Invus Global Management, LLCother entity | 7.7M | 4.3% | 2026-03-31 |
| 2026-05-04 | 13G/Ano. 1 | Siren, L.L.C.other entity | 7.7M | 4.3% | 2026-03-31 |
| 2026-05-04 | 13G/Ano. 1 | Invus Public Equities, L.P.partnership | 7.7M | 4.3% | 2026-03-31 |
| 2026-05-04 | 13G/Ano. 1 | Invus Public Equities Advisors, LLCother entity | 7.7M | 4.3% | 2026-03-31 |
| 2026-05-04 | 13G/Ano. 1 | Avicenna Life Sci Master Fund LPpartnership | 758K | 0.4% | 2026-03-31 |
| 2026-05-04 | 13G/Ano. 1 | Ulys, L.L.C.other entity | 758K | 0.4% | 2026-03-31 |
| 2026-05-04 | 13G/Ano. 1 | Avicenna Life Sci Master GP LLCother entity | 758K | 0.4% | 2026-03-31 |
| 2026-04-01 | 13D/Ano. 4 | Kristina Burowindividual | 34.0M | 18.7% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | ARCH Venture Partners XII, LLCother entity | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | Robert Nelsenindividual | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | Keith Crandellindividual | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | ARCH Venture Partners X Overage, L.P.partnership | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | ARCH Venture Fund VII, L.P.partnership | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | ARCH Venture Fund VIII Overage, L.P.partnership | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | ARCH Venture Fund X, L.P.partnership | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | ARCH Venture Fund X Overage, L.P.partnership | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | ARCH Venture Fund XII, L.P.partnership | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | ARCH Venture Partners VII, L.P.partnership | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | ARCH Venture Partners X, L.P.partnership | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | ARCH Venture Partners XII, L.P.partnership | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | ARCH Venture Partners VII, LLCother entity | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | ARCH Venture Partners VIII, LLCother entity | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | ARCH Venture Partners X, LLCother entity | 33.8M | 18.6% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | Steven Gillisindividual | 31.5M | 17.3% | 2026-03-30 |
| 2026-04-01 | 13D/Ano. 4 | Clinton Bybeeindividual | 3.7M | 2.0% | 2026-03-30 |
13F holders
Tracked managers holding NMRA at their latest 13F. JSON5 of the 30 tracked managers held NMRA at their latest 13F, $8.3M in total at quarter-end prices. Two Sigma Investments is the largest at $3.8M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 2.2M | $3.8M | 0.00% | +208K |
| Renaissance Technologies | 2026-06-30 | 1.3M | $2.1M | 0.00% | -127K |
| Citadel Advisors | 2026-06-30 | 829K | $1.4M | 0.00% | +485K |
| Millennium Management | 2026-06-30 | 509K | $866K | 0.00% | -2.2M |
| AQR Capital Management | 2026-06-30 | 14K | $23K | 0.00% | -42K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Neumora Therapeutics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Neumora Therapeutics (NMRA), SEC CIK 1885522, listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances). The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-21.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-21.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-05-15.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-14.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-21.JSON and CSV
- Company record
- EDGAR filing index for CIK 1885522Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as biological products, (no diagnostic substances)
Other company pages
Datasets
Frequently Asked Questions
How much of NMRA is sold short?
6,692,034 shares were held short at the 2026-09-30 settlement, 2.7 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is NMRA's daily short volume?
On 2026-10-23, 303,879 of the 426,051 NMRA shares reported to FINRA were sold short, 71.3% of the day's reported volume. Short volume is a flow for one day, not a position.
Does NMRA have fails to deliver?
The SEC's latest file shows 2,250 NMRA shares failed to deliver at settlement 2026-09-21. Fails are reported per settlement date and published twice a month with a lag.
Are NMRA insiders buying or selling?
Insiders at NMRA reported 11 open-market sells worth $702K in the last 90 days and no open-market buys. Latest filing: Aurora Daljit Singh (See Remarks) on 2026-08-21.
Have NMRA insiders filed to sell?
10 Form 144 notices on file for NMRA worth $1.1M at the prices reported; 5 in the last 90 days worth $702K. Latest: Aurora Daljit Singh filed on 2026-08-21 to sell 41,608 shares ($66K) from 2026-08-21.
Who owns 5% or more of NMRA?
17 holders report 5% or more of NMRA in their latest filing, all on Schedule 13D (active intent). The largest reported stake is Kristina Burow at 18.7% of the class (33,965,419 shares), filed 2026-04-01 for an event on 2026-03-30.
Which tracked 13F managers own NMRA?
5 of the 30 tracked 13F managers held NMRA shares at their latest filing, $8.3M in all. The largest: Two Sigma Investments (2.2M shares, $3.8M), Renaissance Technologies (1.3M shares, $2.1M), Ken Griffin's Citadel Advisors (829K shares, $1.4M), Izzy Englander's Millennium Management (509K shares, $866K), Cliff Asness's AQR Capital Management (14K shares, $23K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.